Press Releases and Media Coverage
May 13, 2024
Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor
Read Article
April 26, 2022
Pheast Raises $76M in Series A Funding to Train the Immune System to Feast on Cancer
Read Article